Aimed Bio Inc. (KOSDAQ:0009K0)

Aimed Bio Statistics

Total Valuation

Aimed Bio has a market cap or net worth of KRW 3.08 trillion. The enterprise value is 2.74 trillion.

Market Cap	3.08T
Enterprise Value	2.74T

Important Dates

The next estimated earnings date is Monday, April 13, 2026.

Earnings Date	Apr 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Aimed Bio has 64.67 million shares outstanding.

Current Share Class	64.67M
Shares Outstanding	64.67M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.37%
Owned by Institutions (%)	10.39%
Float	22.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	279.71
PS Ratio	32.52
PB Ratio	7.98
P/TBV Ratio	8.05
P/FCF Ratio	98.32
P/OCF Ratio	96.15
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 63.73, with an EV/FCF ratio of 87.46.

EV / Earnings	-12,875.14
EV / Sales	28.93
EV / EBITDA	63.73
EV / EBIT	65.85
EV / FCF	87.46

Financial Position

The company has a current ratio of 22.16, with a Debt / Equity ratio of 0.00.

Current Ratio	22.16
Quick Ratio	22.05
Debt / Equity	0.00
Debt / EBITDA	0.04
Debt / FCF	0.06
Interest Coverage	728.30

Financial Efficiency

Return on equity (ROE) is -0.10% and return on invested capital (ROIC) is 10.88%.

Return on Equity (ROE)	-0.10%
Return on Assets (ROA)	10.35%
Return on Invested Capital (ROIC)	10.88%
Return on Capital Employed (ROCE)	10.74%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.38
Inventory Turnover	n/a

Taxes

Income Tax	-9.18B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	54,893.00
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.24
Average Volume (20 Days)	340,497

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aimed Bio had revenue of KRW 94.56 billion and -212.45 million in losses.

Revenue	94.56B
Gross Profit	94.56B
Operating Income	41.54B
Pretax Income	-9.40B
Net Income	-212.45M
EBITDA	42.92B
EBIT	41.54B
Earnings Per Share (EPS)	101.00

Balance Sheet

The company has 341.66 billion in cash and 1.80 billion in debt, with a net cash position of 339.85 billion or 5,255.08 per share.

Cash & Cash Equivalents	341.66B
Total Debt	1.80B
Net Cash	339.85B
Net Cash Per Share	5,255.08
Equity (Book Value)	385.14B
Book Value Per Share	n/a
Working Capital	339.76B

Cash Flow

In the last 12 months, operating cash flow was 31.98 billion and capital expenditures -707.37 million, giving a free cash flow of 31.28 billion.

Operating Cash Flow	31.98B
Capital Expenditures	-707.37M
Depreciation & Amortization	1.38B
Net Borrowing	-538.39M
Free Cash Flow	31.28B
FCF Per Share	483.62

Margins

Gross margin is 100.00%, with operating and profit margins of 43.93% and -0.22%.

Gross Margin	100.00%
Operating Margin	43.93%
Pretax Margin	-9.94%
Profit Margin	-0.22%
EBITDA Margin	45.39%
EBIT Margin	43.93%
FCF Margin	33.08%

Dividends & Yields

Aimed Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-0.01%
FCF Yield	1.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aimed Bio has an Altman Z-Score of 127.91 and a Piotroski F-Score of 4.

Altman Z-Score	127.91
Piotroski F-Score	4